Huperzine A provides robust and sustained protection against induced seizures in Scn1a mutant mice
De novo loss-of-function mutations in the voltage-gated sodium channel (VGSC) SCN1A (encoding Nav1.1) are the main cause of Dravet syndrome (DS), a catastrophic early-life encephalopathy associated with prolonged and recurrent early-life febrile seizures (FSs), refractory afebrile epilepsy, cognitiv...
Main Authors: | Jennifer C. Wong, Stacey B.B. Dutton, Stephen D. Collins, Steven Schachter, Andrew Escayg |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2016-10-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fphar.2016.00357/full |
Similar Items
-
Identification of five novel SCN1A variants
by: Baitao Zeng, et al.
Published: (2023-11-01) -
Phenotypic and Genotypic Characteristics of SCN1A Associated Seizure Diseases
by: Chunhong Chen, et al.
Published: (2022-04-01) -
Cannabidiol Increases Seizure Resistance and Improves Behavior in an Scn8a Mouse Model
by: Lindsey Shapiro, et al.
Published: (2022-01-01) -
Genetic epilepsy with febrile seizures plus – an overview
by: Madalina Radu, et al.
Published: (2021-03-01) -
Influence of SCN1A Gene Mutation on Age of Onset of Febrile Seizures in GEFS+
by: J Gordon Millichap
Published: (2009-05-01)